Navigation Links
BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
Date:7/16/2013

LYNBROOK, N.Y., July 16, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S, today announced that its partner Auxilium Pharmaceuticals, Inc. (Auxilium) has entered into a collaboration with Swedish Orphan Biovitrum AB (Sobi) for the long-term development, supply and commercialization of XIAPEX (collagenase clostridium histolyticum) for the treatment of Dupuytren's contracture.  Additionally, the process is underway to file for approval of XIAPEX for the treatment of Peyronie's disease in the EU.

"We believe this strategic collaboration with Sobi will enable further growth of XIAPEX in the EU and additional regions.  The expanded sales territory now includes a total of 71 countries which will continue the upward momentum of getting this treatment to new audiences. Sobi has a proven track record of commercializing innovative products and we are excited about reaching patients with these unmet medical needs through this collaboration," reflected Thomas L. Wegman, President of BioSpecifics. "We look forward to further news this quarter with the potential approval of XIAFLEX in the U.S. for Peyronie's disease."

According to Auxilium, Sobi will receive exclusive rights to commercialize XIAPEX for Dupuytren's contracture in 71 Eurasian and African countries under this agreement. Sobi will receive exclusive rights to commercialize XIAPEX for Dupuytren's contracture and Peyronie's disease, subject to applicable regulatory approvals, in 28 EU member countries, Switzerland, Norway, Iceland, 18 Central Eastern Europe/Commonwealth of Independent countries, including Russia'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
2. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
3. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
4. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
5. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
6. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
8. UV Flu Technologies Expands Its International Footprint
9. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
10. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
11. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... of tension to a chain of carbon atoms can ... according to Rice University scientists. , Stretching the material ... carbon atoms -- by just 3 percent can begin ... find useful for mechanically activated nanoscale electronics and optics. ... and his colleagues appears in the American Chemical Society ...
(Date:7/21/2014)... yield so far is small, but chemists at the ... substitution process to make a precursor to transparent thin ... energy devices. , A paper describing the approach is ... of the journal Inorganic Chemistry , which draws ... nuclear chemistry fields. The paper was chosen by the ...
(Date:7/21/2014)... , July 21, 2014 ... & USA Cancer Biomaker ... Forecasts ResearchMoz presents this most up-to-date ...   to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, ... Pipeline Analysis. GLOBAL & ...
(Date:7/20/2014)... nuclear fuel gets recycled, the process releases radioactive krypton ... basements with the related gas radon. A new porous ... appearing July 20 in Nature Materials shows ... but not out. , The CC3 material could ... from nuclear fuel or air in buildings and also ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Oregon chemists eye improved thin films with metal substitution 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6A noble gas cage 2A noble gas cage 3
... - Pipeline Update Conference Call and Webcast on May ... May 8 Halozyme Therapeutics, Inc.,(Nasdaq: HALO ), ... matrix, today reported financial,results for the three months ended ... a solid start as we significantly advanced both,our partnered ...
... ... U.S. ThermaCool NXT System Sales Grow 29% ... ), a leader in non-invasive tissue tightening in the aesthetic,industry, reported ... Revenue for the first quarter of 2008 was $16.2 million, ...
... Inc.,(Nasdaq: NUVO ) today announced first quarter 2008 financial ... first quarter ended March 31, 2008, Nuvelo reported a net ... net loss of $15.3,million, or $0.29 per share, for the ... due to $4.0 million in restructuring and facility,exit charges taken ...
Cached Biology Technology:Halozyme Therapeutics Reports 2008 First Quarter Financial Results 2Halozyme Therapeutics Reports 2008 First Quarter Financial Results 3Halozyme Therapeutics Reports 2008 First Quarter Financial Results 4Halozyme Therapeutics Reports 2008 First Quarter Financial Results 5Halozyme Therapeutics Reports 2008 First Quarter Financial Results 6Halozyme Therapeutics Reports 2008 First Quarter Financial Results 7Halozyme Therapeutics Reports 2008 First Quarter Financial Results 8Halozyme Therapeutics Reports 2008 First Quarter Financial Results 9Thermage Announces First Quarter 2008 Financial Results 2Thermage Announces First Quarter 2008 Financial Results 3Thermage Announces First Quarter 2008 Financial Results 4Thermage Announces First Quarter 2008 Financial Results 5Thermage Announces First Quarter 2008 Financial Results 6Thermage Announces First Quarter 2008 Financial Results 7Thermage Announces First Quarter 2008 Financial Results 8Thermage Announces First Quarter 2008 Financial Results 9Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008 2Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008 3Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008 4Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008 5Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008 6
(Date:7/21/2014)... stuffing yourself full of high-fat foods cause you to ... from Florida State University neuroscientists says so, and it ... diets could impact a whole range of human functions ... of obesity. , "This opens up a lot of ... researcher Nicolas Thiebaud, who led the study examining how ...
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
(Date:7/21/2014)... regulate their body temperature, so their cells are stressed ... colder temperatures, some biological processes in the cell are ... cells, delicate chemical balance out of whack. Yet, those ... researchers from the University of Rochester and the European ... that. , "The production of proteins is a ...
Breaking Biology News(10 mins):New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2
... In our everyday life, we use gasoline, diesel, ... fossil oil through petrochemical refinery processes. However, this is ... resources. Furthermore, our world is facing problems associated with ... increasing use of fossil resources. One solution to address ...
... publisher BioMed Central revealed the winners of their 6th ... UK. Celebrating the very best research that has been ... guests attended the prestigious ceremony including leading researchers, shortlisted ... The winners were selected by internationally renowned judges ...
... a Smart car, with a shell large enough to double ... have found just such a specimen the fossilized remains ... is now Colombia. The turtle in question is ... of a group of side-necked turtles known as pelomedusoides. The ...
Cached Biology News:Production of chemicals without petroleum 2BioMed Central announces winners of 6th Annual Research Awards 2Ancient giant turtle fossil revealed 2
... raised against a partial recombinant ... PPP4C (NP_002711, 218 a.a. ... protein with GST tag. ... NM_002720 Protein ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
Biology Products: